These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 24112770)
1. Discovering isozyme-selective inhibitor scaffolds of human carbonic anhydrases using structural alignment and de novo drug design approaches. Xiang F; Xiang J; Fang Y; Zhang M; Li M Chem Biol Drug Des; 2014 Feb; 83(2):247-58. PubMed ID: 24112770 [TBL] [Abstract][Full Text] [Related]
2. Benzimidazole design, synthesis, and docking to build selective carbonic anhydrase VA inhibitors. Čapkauskaitė E; Zakšauskas A; Ruibys V; Linkuvienė V; Paketurytė V; Gedgaudas M; Kairys V; Matulis D Bioorg Med Chem; 2018 Feb; 26(3):675-687. PubMed ID: 29305297 [TBL] [Abstract][Full Text] [Related]
3. Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX. Thiry A; Ledecq M; Cecchi A; Dogné JM; Wouters J; Supuran CT; Masereel B J Med Chem; 2006 May; 49(9):2743-9. PubMed ID: 16640335 [TBL] [Abstract][Full Text] [Related]
4. Homology modeling and receptor-based 3D-QSAR study of carbonic anhydrase IX. Tuccinardi T; Ortore G; Rossello A; Supuran CT; Martinelli A J Chem Inf Model; 2007; 47(6):2253-62. PubMed ID: 17949069 [TBL] [Abstract][Full Text] [Related]
5. S-glycosyl primary sulfonamides--a new structural class for selective inhibition of cancer-associated carbonic anhydrases. Lopez M; Paul B; Hofmann A; Morizzi J; Wu QK; Charman SA; Innocenti A; Vullo D; Supuran CT; Poulsen SA J Med Chem; 2009 Oct; 52(20):6421-32. PubMed ID: 19827837 [TBL] [Abstract][Full Text] [Related]
6. Inhibition pattern of sulfamide-related compounds in binding to carbonic anhydrase isoforms I, II, VII, XII and XIV. Gavernet L; Gonzalez Funes JL; Palestro PH; Bruno Blanch LE; Estiu GL; Maresca A; Barrios I; Supuran CT Bioorg Med Chem; 2013 Mar; 21(6):1410-8. PubMed ID: 23266178 [TBL] [Abstract][Full Text] [Related]
7. Salicylaldoxime derivatives as new leads for the development of carbonic anhydrase inhibitors. Tuccinardi T; Bertini S; Granchi C; Ortore G; Macchia M; Minutolo F; Martinelli A; Supuran CT Bioorg Med Chem; 2013 Mar; 21(6):1511-5. PubMed ID: 23018095 [TBL] [Abstract][Full Text] [Related]
8. 3D QSAR selectivity analyses of carbonic anhydrase inhibitors: insights for the design of isozyme selective inhibitors. Weber A; Böhm M; Supuran CT; Scozzafava A; Sotriffer CA; Klebe G J Chem Inf Model; 2006; 46(6):2737-60. PubMed ID: 17125213 [TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. Pastorekova S; Parkkila S; Pastorek J; Supuran CT J Enzyme Inhib Med Chem; 2004 Jun; 19(3):199-229. PubMed ID: 15499993 [TBL] [Abstract][Full Text] [Related]
10. Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide. Di Fiore A; Monti SM; Hilvo M; Parkkila S; Romano V; Scaloni A; Pedone C; Scozzafava A; Supuran CT; De Simone G Proteins; 2009 Jan; 74(1):164-75. PubMed ID: 18618712 [TBL] [Abstract][Full Text] [Related]
11. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Alterio V; Di Fiore A; D'Ambrosio K; Supuran CT; De Simone G Chem Rev; 2012 Aug; 112(8):4421-68. PubMed ID: 22607219 [No Abstract] [Full Text] [Related]
12. Designing of novel carbonic anhydrase inhibitors and activators. Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):49-68. PubMed ID: 15328829 [TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-ray crystallographic studies for the indapamide-isozyme II adduct. Temperini C; Cecchi A; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2008 Apr; 18(8):2567-73. PubMed ID: 18374572 [TBL] [Abstract][Full Text] [Related]
14. Crystal structure of carbonic anhydrase from Neisseria gonorrhoeae and its complex with the inhibitor acetazolamide. Huang S; Xue Y; Sauer-Eriksson E; Chirica L; Lindskog S; Jonsson BH J Mol Biol; 1998; 283(1):301-10. PubMed ID: 9761692 [TBL] [Abstract][Full Text] [Related]
15. Characterization of human carbonic anhydrase XII stability and inhibitor binding. Jogaitė V; Zubrienė A; Michailovienė V; Gylytė J; Morkūnaitė V; Matulis D Bioorg Med Chem; 2013 Mar; 21(6):1431-6. PubMed ID: 23159038 [TBL] [Abstract][Full Text] [Related]
17. 4-Substituted-2,3,5,6-tetrafluorobenzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, XII, and XIII. Dudutienė V; Zubrienė A; Smirnov A; Gylytė J; Timm D; Manakova E; Gražulis S; Matulis D Bioorg Med Chem; 2013 Apr; 21(7):2093-106. PubMed ID: 23394791 [TBL] [Abstract][Full Text] [Related]
18. Design of [(2-pyrimidinylthio)acetyl]benzenesulfonamides as inhibitors of human carbonic anhydrases. Čapkauskaitė E; Zubrienė A; Baranauskienė L; Tamulaitienė G; Manakova E; Kairys V; Gražulis S; Tumkevičius S; Matulis D Eur J Med Chem; 2012 May; 51():259-70. PubMed ID: 22440859 [TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides. Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998 [TBL] [Abstract][Full Text] [Related]